Reporting owner · CIK 0001985496

Ye Weiguo

SEC Form 4 history for the last 180 days across 1 company, 6 transactions and 1 filing.

COOChief Operating OfficerGYRE THERAPEUTICS, INC.
Open-market transaction mix0% buys0 buys · 2 sales

Period: Last 180 days

Trade dates in this period: May 22, 2026 – May 26, 2026

Transaction history, summary figures and purchase returns cover the last 180 days. Earlier activity is excluded from those sections.

Filings1Form 4 records
Buying$00 purchases
Selling$45.7k2 sales
Net value−$45.7kBuys minus sells · disclosed values

Latest insider transactions

Form 4 filings from the last 180 days.
Ye Weiguo transactions · 20 per page
CompanyActivityDisclosed valueFiled (ET)
GYREGYRE THERAPEUTICS, INC.
Chief Operating Officer
COO
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Derivative securitySEC filing ↗
$0View disclosure →
GYREGYRE THERAPEUTICS, INC.
Chief Operating Officer
COO
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Derivative securitySEC filing ↗
$0View disclosure →
GYREGYRE THERAPEUTICS, INC.
Chief Operating Officer
COO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$24.4kView disclosure →
GYREGYRE THERAPEUTICS, INC.
Chief Operating Officer
COO
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
SEC filing ↗
$3.00kView disclosure →
GYREGYRE THERAPEUTICS, INC.
Chief Operating Officer
COO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$21.3kView disclosure →
GYREGYRE THERAPEUTICS, INC.
Chief Operating Officer
COO
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
SEC filing ↗
$2.63kView disclosure →

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

The insider reported a sale at GYRE THERAPEUTICS, INC. on May 26, 2026 valued at $24,400.40.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Monthly open-market activity

Last 1 reported month · purchases and sales

View exact monthly values
Monthly open-market source values
MonthPurchasesSalesBuy valueSale valueNet value
May 202602$0$45,680.40−$45,680.40

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size$22.8k
Median P/S size$22.8k
Direct6
Indirect0
May 26, 2026exercise

Filing-only signals

Deterministic matches in this insider's history

Associated companies

Counts cover all available history, including outside the summary period

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
No open-market purchases in the last 180 days

A 90-day purchase return requires an open-market buy. None is recorded in the last 180 days. Purchases filed earlier are outside the visible history and are not included.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

4 observations · May 22, 2026 – May 26, 2026. Window ends at the latest available report, not today.

Selected observation · May 26, 2026700,000 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
May 22, 2026703,500May 27, 2026View transaction
May 22, 2026700,000May 27, 2026View transaction
May 26, 2026704,000May 27, 2026View transaction
May 26, 2026700,000May 27, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Ye Weiguo Insider Activity FAQ

SEC Form 4 context

Who is Ye Weiguo?

Ye Weiguo is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001985496.

Which companies has Ye Weiguo reported transactions for?

GYRE THERAPEUTICS, INC.

When was Ye Weiguo's latest insider buy?

No open-market insider purchase is recorded in the last 180 days. Earlier filings are outside the visible history.

When was Ye Weiguo's latest insider sale?

The insider reported a sale at GYRE THERAPEUTICS, INC. on May 26, 2026 valued at $24,400.40.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.